Lee PP - Search Results

1

Characterization of circulating T cells specific for tumor-associated antigens in melanoma patients.

Lee PP, Yee C, Savage PA, Fong L, Brockstedt D, Weber JS, Johnson D, Swetter S, Thompson J, Greenberg PD, Roederer M, Davis MM. Lee PP, et al. Nat Med. 1999 Jun;5(6):677-85. doi: 10.1038/9525. Nat Med. 1999. PMID: 10371507

2

Isolation of high avidity melanoma-reactive CTL from heterogeneous populations using peptide-MHC tetramers.

Yee C, Savage PA, Lee PP, Davis MM, Greenberg PD. Yee C, et al. Among authors: lee pp. J Immunol. 1999 Feb 15;162(4):2227-34. J Immunol. 1999. PMID: 9973498

3

Evidence that specific T lymphocytes may participate in the elimination of chronic myelogenous leukemia.

Molldrem JJ, Lee PP, Wang C, Felio K, Kantarjian HM, Champlin RE, Davis MM. Molldrem JJ, et al. Among authors: lee pp. Nat Med. 2000 Sep;6(9):1018-23. doi: 10.1038/79526. Nat Med. 2000. PMID: 10973322

4

Melanocyte destruction after antigen-specific immunotherapy of melanoma: direct evidence of t cell-mediated vitiligo.

Yee C, Thompson JA, Roche P, Byrd DR, Lee PP, Piepkorn M, Kenyon K, Davis MM, Riddell SR, Greenberg PD. Yee C, et al. Among authors: lee pp. J Exp Med. 2000 Dec 4;192(11):1637-44. doi: 10.1084/jem.192.11.1637. J Exp Med. 2000. PMID: 11104805 Free PMC article.

5

The use of HLA A2.1/p53 peptide tetramers to visualize the impact of self tolerance on the TCR repertoire.

Hernández J, Lee PP, Davis MM, Sherman LA. Hernández J, et al. Among authors: lee pp. J Immunol. 2000 Jan 15;164(2):596-602. doi: 10.4049/jimmunol.164.2.596. J Immunol. 2000. PMID: 10623800

6

Methods for Use of Peptide-MHCTetramers in Tumor Immunology.

Yee C, Lee PP. Yee C, et al. Among authors: lee pp. Methods Mol Med. 2001;61:353-62. doi: 10.1385/1-59259-145-0:353. Methods Mol Med. 2001. PMID: 22323268

7

A PR1-human leukocyte antigen-A2 tetramer can be used to isolate low-frequency cytotoxic T lymphocytes from healthy donors that selectively lyse chronic myelogenous leukemia.

Molldrem JJ, Lee PP, Wang C, Champlin RE, Davis MM. Molldrem JJ, et al. Among authors: lee pp. Cancer Res. 1999 Jun 1;59(11):2675-81. Cancer Res. 1999. PMID: 10363991

8

Chronic myelogenous leukemia shapes host immunity by selective deletion of high-avidity leukemia-specific T cells.

Molldrem JJ, Lee PP, Kant S, Wieder E, Jiang W, Lu S, Wang C, Davis MM. Molldrem JJ, et al. Among authors: lee pp. J Clin Invest. 2003 Mar;111(5):639-47. doi: 10.1172/JCI16398. J Clin Invest. 2003. PMID: 12618518 Free PMC article.

9

Systems profiling reveals recurrently dysregulated cytokine signaling responses in ER+ breast cancer patients' blood.

Orcutt-Jahns B, Lima Junior JR, Lin E, Rockne RC, Matache A, Branciamore S, Hung E, Rodin AS, Lee PP, Meyer AS. Orcutt-Jahns B, et al. Among authors: lee pp. NPJ Syst Biol Appl. 2024 Oct 10;10(1):118. doi: 10.1038/s41540-024-00447-0. NPJ Syst Biol Appl. 2024. PMID: 39389979 Free PMC article.

10

Tumor draining lymph nodes connected to cold triple-negative breast cancers are characterized by Th2-associated microenvironment.

Guo W, Tan J, Wang L, Egelston CA, Simons DL, Ochoa A, Lim MH, Wang L, Solomon S, Waisman J, Wei CH, Hoffmann C, Song J, Schmolze D, Lee PP. Guo W, et al. Among authors: lee pp. Nat Commun. 2024 Oct 4;15(1):8592. doi: 10.1038/s41467-024-52577-y. Nat Commun. 2024. PMID: 39366933 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

635 results

Search Page

Filters